Effectiveness of pharmacogenomic testing across age groups for depressive disorder treatment and its age-dependent effects on cognitive function: A randomized controlled trial
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.121065 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Liyin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University(Tongde Hospital of Zhejiang Province), Hangzhou, China. Hauptthemen laut MEDLINE: Pharmacogenomic Testing, Cognition, Antidepressive Agents, Major Depressive Disorder. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Province Natural Science Foundation, Key Research and Development Program of Zhejiang Province, National Science and Technology Major Project.
Abstract (Originalsprache)
BACKGROUND: Pharmacogenomic testing may optimize antidepressant treatment in depression. Its effects on cognition and across age groups remain unclear. METHODS: A total of 843 patients with depressive disorder were stratified by age (adolescent, young adult, middle-aged, elderly) and assigned to pharmacogenomic-guided or treatment-as-usual groups. Guided treatment was based on pharmacogenomic results. Primary outcomes were changes in Montreal Cognitive Assessment (MoCA), remission (HDRS
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University(Tongde Hospital of Zhejiang Province), Hangzhou, China.
- Department of Geriatric Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Department of Psychiatry, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Psychiatry, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Electronic address: zll121@zju.edu.cn.
- Department of Psychiatry, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Electronic address: 2194026@zju.edu.cn.
Förderung
- Zhejiang Province Natural Science Foundation
- Key Research and Development Program of Zhejiang Province
- National Science and Technology Major Project
Zitieren
APA
Li, L., Xu, L., Wang, Q., Sun, Z., Han, Y., Zheng, L., & Lin, Z. (2026). Effectiveness of pharmacogenomic testing across age groups for depressive disorder treatment and its age-dependent effects on cognitive function: A randomized controlled trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.121065
Vancouver
Li L, Xu L, Wang Q, Sun Z, Han Y, Zheng L, et al. Effectiveness of pharmacogenomic testing across age groups for depressive disorder treatment and its age-dependent effects on cognitive function: A randomized controlled trial. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.121065
BibTeX
@article{Li2026,
author = {Li, Liyin and Xu, Lei and Wang, Qiutang and Sun, Ziqi and Han, Yuhang and Zheng, Leilei and Lin, Zheng},
title = {Effectiveness of pharmacogenomic testing across age groups for depressive disorder treatment and its age-dependent effects on cognitive function: A randomized controlled trial},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.121065}
}
EUVIMED